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ABSTRACT: This paper describes the molecular recognition of the tripeptide Tyr-Leu-Ala by the synthetic receptor 
cucurbit[8]uril (Q8) in aqueous buffer, with nanomolar affinity, and with exceptional specificity. This combination of 
characteristics, which also applies to antibodies, is desirable for applications in biochemistry and biotechnology but has eluded 
supramolecular chemists for decades. Building on prior knowledge that Q8 binds to peptides with N-terminal aromatic residues, a 
library screen of 105 peptides was designed to test the effects of residues adjacent to N-terminal Trp, Phe, or Tyr. The screen used 
tetramethylbenzobis(imidazolium) (MBBI) as a fluorescent indicator and resulted in the unexpected discovery that MBBI can serve 
not only as a turn-off sensor via the simultaneous inclusion of a Trp residue, but also as a turn-on sensor via the competitive 
displacement of MBBI upon binding of Phe- or Tyr-terminated peptides. The unusual fluorescence response of the Tyr series 
prompted further investigation by 1H NMR spectroscopy, electrospray ionization mass spectrometry, and isothermal titration 
calorimetry. From these studies, a novel binding motif was discovered in which only one equivalent of peptide binds to Q8, and the 
sidechains of both the N-terminal Tyr residue and its immediate neighbor bind within the Q8 cavity. For the peptide Tyr-Leu-Ala, 
the equilibrium dissociation constant value is 7.2 nM, whereas that of its sequence isomer Tyr-Ala-Leu is 34 M. The high 
stability, recyclability, and low cost of Q8 combined with the straightforward incorporation of Tyr-Leu-Ala into recombinant 
proteins should make this system attractive for the development of biological applications. 
INTRODUCTION 
The discovery and development of synthetic compounds that can recognize specific peptides and 
proteins underpins the effort to interface with living systems. One of the principal technological 
successes in this area includes monoclonal antibodies, which bind their peptide targets with equilibrium 
dissociation constant (Kd) values in the nanomolar range and with exquisite specificity.
1 Supramolecular 
chemists have developed a wide range of synthetic receptors for peptides in aqueous solution,2-9 but 
most have Kd values in the micromolar to millimolar range. Compared to antibodies, however, synthetic 
receptors offer the advantages of being more economical to produce, more stable, more scalable, and 
more reliable. These advantages, however, will only become relevant for biological applications if the 
receptor can recognize a peptide in aqueous solution, at nanomolar concentrations, and with at least 
1000-fold sequence specificity, as described here for the synthetic receptor cucurbit[8]uril (Q8). 
Q8 (Figure 1) derives from the cucurbit[n]uril (Qn) family of organic macrocycles,10 which have 
earned distinction for their capacity to encapsulate a wide array of organic molecules in primarily 
aqueous media with Kd values that can extend to attomolar levels.
11-13 Numerous Qn homologues,14,15 
derivatives,16-20 and acyclic congeners21 have extended the family to myriad structures and 
applications.22 Q8 and its homologue cucurbit[7]uril (Q7) have been shown to bind amino acids, 
peptides, and proteins, with preference for the aromatic residues tryptophan (Trp), phenylalanine (Phe), 
and tyrosine (Tyr), especially when located at the N-terminal position in the polypeptide chain.6 An N-
terminal aromatic residue is recognized in the same fashion as many other Qn-based guests, which is by 
inclusion of the hydrophobic group (the side chain) within the nonpolar cavity and stabilization of the 
cationic group (the N-terminal ammonium) with the carbonyl oxygens that surround the two constricted 
entrances to the Qn cavity. Q8 is large enough to include two aromatic guests within its cavity,23,24 and 
the earliest report of peptide recognition by the Qn family25 involved a ternary complex of Q8 with 
methyl viologen (MV) and the indole sidechain of a Trp-containing peptide. In this system, Q8 binds 
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first to MV, and the Q8•MV complex then binds to the indole side chain of a Trp-containing peptide. 
Specificity for Trp at the N-terminal position is gained by interaction with the N-terminal ammonium 
group when it is part of the Trp residue and thus proximal to the indole side chain. 
In order to explore the scope and limitations of affinity and selectivity in the Q8•MV•Trp system, 
we studied the effects of residues adjacent to Trp and found little, if any, influence on binding to 
Q8•MV.26 That study, however, was limited to Trp-containing peptides due to the need for a 
fluorophore. We have shown that MV can be replaced by tetramethyl benzobis(imidazolium) (MBBI) 
while still maintaining the molecular recognition properties for Trp-containing peptides.27 The intrinsic 
fluorescence of MBBI broadens the scope of possible analytes to include nonfluorescent guests, thus 
enabling the exploration of a larger peptide sequence space, the first report of which is presented here. 
 
RESULTS AND DISCUSSION  
Design and screen of a peptide library.  A peptide library (Figure 1) was designed to examine the 
effects of amino acid sequence on the binding of Q8 to peptides containing an aromatic residue at the N-
terminus. All compounds were tripeptides comprising natural, unmodified side chains. The N-terminal 
residue was Trp, Phe, or Tyr. The residue immediately adjacent to the N-terminal residue (Var1) or two 
residues away (Var2) was varied among 18 genetically encoded amino acids while holding the other 
position in the tripeptide constant with an alanine (Ala) residue. Trp and cysteine (Cys) were not 
included at the variable positions due to the complications introduced by having a second Trp binding 
site and to the fact that Cys residues form disulfide bonds under ambient conditions. This design yielded 
a library of 105 peptides (leaving out replicates when Var1 = Var2 = Ala). The library was synthesized 
by parallel solid-phase synthesis on Rink amide Lantern resins, and thus all C-termini were primary 
amides. 
 
Figure 1. Chemical formulas and peptides sequences used in this study. 
 
Central to the assay design is the fluorophore MBBI,27 which was shown previously to have 
molecular recognition properties similar to MV but with the advantages of intrinsic fluorescence, higher 
chemical and thermal stability, and greater synthetic tunability. Q8 binds to MBBI with a Kd value of 
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1.2 M, and the Q8•MBBI complex binds to Trp-containing peptides with affinities and sequence 
specificities that are remarkably similar to those of the Q8•MV complex. The simultaneous binding of 
MBBI and a second guest within the Q8 cavity quenches the intrinsic fluorescence of MBBI, and thus 
the Q8•MBBI complex can be used to sense the binding of both fluorescent and non-fluorescent guests. 
The peptide library was screened for binding to Q8•MBBI by measuring the change in the 
fluorescence intensity of Q8•MBBI upon the addition of each peptide in 10 mM sodium phosphate 
solution, pH 7.0, at room temp. A comparison of the 35 peptides containing an N-terminal Trp residue 
(Figure S52) revealed that the fluorescence intensity of Q8•MBBI generally decreased upon binding to 
the Trp-containing peptides, as expected.27 Compared to Q8•MBBI, fluorescence intensities decreased 
by 4% to 57%, and in the singular case of Trp-Phe-Ala, the intensity increased by 4%. The decrease in 
fluorescence intensity indicates the simultaneous inclusion of MBBI and the indole side chain of Trp 
within the cavity of Q8, as observed previously.27 For the 35 peptides containing an N-terminal Phe 
residue (Figure S51), fluorescence increased for all peptides, covering the range 0.45% to 24%. This 
unexpected increase may be explained in light of two previously reported observations: 1) the 
fluorescence intensity of free MBBI is higher than that of the Q8•MBBI complex;27 and 2) peptides 
containing an N-terminal Phe residue are known to bind to Q8 in a 2:1 peptide:Q8 stoichiometry.28 With 
these observations in mind, we hypothesized that the increase in fluorescence intensity is due to 
displacement of MBBI by the peptide. 
The most curious result of this experiment, however, involved the 35 peptides with an N-terminal 
Tyr residue (Figure 2). In this series, the influence of peptide on the observed fluorescence varied 
significantly and was highly sequence-dependent. Fluorescence intensity decreased for five peptides 
(0.21% to 6.9%) and increased for 13 peptides (0.39% to 21%). In several cases (Var = Leu, Phe, Tyr, 
Met, Thr, Ser, and Asn), the fluorescence intensity increased for the peptide Tyr-Var1-Ala but decreased 
 
 
Figure 2. Fluorescence relative to the Q8•MBBI complex for mixtures of Q8•MBBI with each of 35 tripeptides of sequence 
Tyr-Var1-Ala and Tyr-Ala-Var2. Samples contained 200 M peptide and 40 M Q8•MBBI at room temp in 10 mM sodium 
phosphate, pH 7.0. Values are averages of at least three experiments. Error bars are indicated as the standard deviation. 
for the peptide Tyr-Ala-Var2. This remarkable result suggests that there may be a sequence-dependent 
change in binding mode for these peptides. The largest observed difference (23%) was observed for Var 
= Leu (i.e., Tyr-Leu-Ala versus Tyr-Ala-Leu). These two sequence isomers were therefore chosen for 
in-depth study to further explore this phenomenon. 
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In-Depth Study of Tyr-Leu-Ala and Tyr-Ala-Leu.  In the library screen described above, the 
peptides were synthesized in parallel on 8 mol scale and used without further purification (see 
Supporting Information for experimental details). For the in-depth studies described here, Tyr-Leu-Ala 
and Tyr-Ala-Leu were synthesized individually on 37 mol scale, purified by reversed phase HPLC, 
and characterized by 1H NMR and electrospray ionization mass spectrometry (ESI-MS) (Figures S1, S3, 
S19, and S25). The library screen showed that the fluorescence intensity of Q8•MBBI increased in the 
presence of Tyr-Leu-Ala but decreased in the presence of Tyr-Ala-Leu. In that experiment, however, the 
emission intensity data were collected at only a single wavelength (340 nm). In order to probe any 
additional spectral effects, full emission spectra were acquired for Q8•MBBI in the absence and in the 
presence of Tyr-Leu-Ala and Tyr-Ala-Leu in 10 mM sodium phosphate, pH 7.0 at room temp (Figure 
3). Interestingly, the fluorescence spectrum of the mixture containing Q8, MBBI and Tyr-Leu-Ala is 
essentially identical to that of free MBBI (also shown). This result is consistent with the displacement of 
MBBI from the cavity of Q8 upon binding of Tyr-Leu-Ala. The fluorescence spectrum of the mixture 
containing Q8, MBBI, and Tyr-Ala-Leu, however, shows a decrease in fluorescence intensity as 
compared to that of Q8•MBBI, which is consistent with prior work showing the quenching of Q8•MBBI 
fluorescence upon the inclusion of the side-chain of Trp. Therefore, we hypothesized that a portion of 
Tyr-Ala-Leu was bound within the cavity of the Q8•MBBI complex, and further study was undertaken 
to explore the mode of binding in more detail. 
 
Figure 3. Fluorescence emission spectra (ex=297 nm) acquired at room temp for mixtures containing 40 M MBBI, 40 M 
Q8•MBBI, and 40 M Q8•MBBI in the presence of 200 M peptide, all in 10 mM sodium phosphate, pH 7.0. 
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Figure 4. 500 MHz 1H NMR spectra acquired at 25 C for samples containing (a) MBBI, (b) a 1:1 mixture of Q8 and MBBI, 
(c) a 1:1:1 mixture of Q8, MBBI, and Tyr-Leu-Ala, (d) a 1:1 mixture of Q8 and Tyr-Leu-Ala, (e) a 1:2 mixture of Q8 and 
Tyr-Leu-Ala, and (f) Tyr-Leu-Ala. Samples were approximately 0.5 mM in unbuffered deuterium oxide. 
 
A detailed investigation of the binding of Tyr-terminated peptides was carried out using 1H NMR 
spectroscopy in deuterium oxide at 25 C. Binding of a guest or a portion of a guest within the cavity of 
a cucurbit[n]uril is known to induce an upfield perturbation of the chemical shift of the corresponding 
signals.29 As shown previously,27 and again here (Figure 4 a,b), this phenomenon is observed for MBBI 
in the presence of Q8. Upon addition of one equivalent of Tyr-Leu-Ala to the Q8•MBBI complex (1:1:1 
mixture, Figure 4 c), the chemical shifts of both MBBI signals return to those of free MBBI, whereas all 
signals corresponding to the Tyr and Leu residues move upfield, and those of the Ala residue move 
downfield. Based on these results, an in corroboration with the fluorescence data, we conclude that the 
peptide competitively displaces MBBI from the Q8 cavity. Moreover, it is clear that both Tyr and Leu 
side chains are bound within the cavity of Q8, and that the Ala side chain is located near the Q8 portal. 
In the absence of MBBI, the 1:1 mixture of Tyr-Leu-Ala and Q8 (Figure 4 d) shows identical peptide 
signals as the 1:1:1 mixture of Tyr-Leu-Ala, MBBI, and Q8. This result shows that MBBI does not 
influence the binding mode of Tyr-Leu-Ala with Q8. The 1:2 mixture of Q8 and Tyr-Leu-Ala (Figure 4 
e) has a spectrum that is identical to that of the Q8•Tyr-Leu-Ala complex in addition to a second set of 
resonances corresponding to free peptide (Figure 4 f). These spectra confirm that Tyr-Leu-Ala binds to 
Q8 in a 1:1 stoichiometry and provides evidence that the kinetics of exchange between bound and 
unbound states is slow on the NMR timescale, thus suggesting a slow dissociation rate and a high 
binding affinity. The presence of the 1:1 peptide:Q8 complex was confirmed by ESI-MS (Figure S2). 
The slow exchange kinetics observed for the Q8•Tyr-Leu-Ala complex facilitated the acquisition of 
a ROESY spectrum (Figure S24) in order to gain more information on the conformation of the peptide 
in the complex. Nine NOEs were observed between the side chains of Tyr and Leu residues (inter-
residue, see Table S1), and seventeen NOEs were observed between the peptide and Q8 
(intermolecular). On the basis of these data, a semiempirical computational model was constructed 
(Figure 5) that is consistent with the NMR data. The model shows the side chains of Tyr and Leu 
residues bound snugly within the Q8 cavity. It also suggests electrostatic stabilization of the complex 
via five putative hydrogen bonds between peptide NH and NH3
+ groups and Q8 carbonyl oxygens.  
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Figure 5. Semiempirical model of the Q8•Tyr-Leu-Ala complex. The model was built in Maestro by manually docking the 
peptide to fit the side chains of Tyr and Leu residues inside the Q8 cavity, and then subjecting the model to a geometry 
minimization in the OPLS 2005 molecular mechanics force field with implicit solvent using upper-bound distance restraints 
generated from the nine inter-residue (Tyr-to-Leu) NOEs observed in the ROESY spectrum (Figure S24). 
In contrast to Tyr-Leu-Ala, studies of the sequence isomer Tyr-Ala-Leu reveal substantially 
different results. In the 1H NMR spectrum of Tyr-Ala-Leu combined with Q8 and MBBI (Figure S28), 
the MBBI peaks broaden, but their chemical shifts do not return to those of free MBBI. The Tyr peaks 
shift upfield and broaden substantially, and the Ala and Leu peaks broaden slightly, but their chemical 
shifts do not change appreciably. These observations corroborate with the fluorescence data to 
demonstrate that MBBI and Tyr are bound simultaneously within the Q8 cavity. When Tyr-Ala-Leu is 
combined with Q8 (Figure S26), the Tyr peaks perturb upfield significantly, and they broaden but not as 
much as when MBBI is present. The Ala and Leu peaks broaden slightly, and their chemical shifts do 
not perturb significantly. In the 2:1 Tyr-Ala-Leu:Q8 mixture (Figure S27), the peaks observed in the 1:1 
mixture broaden much further, and no new set of peaks was observed. These results suggest that 
chemical exchange kinetics are intermediate on the NMR time scale and are consistent with low-affinity 
binding. Unfortunately, the lack of spectral resolution limits the depth of the NMR analysis. It is clear, 
however, that the peaks corresponding only to the side chain of Tyr experience a significant upfield 
perturbation in chemical shift in the presence of Q8, and thus we conclude that only Tyr binds within 
the Q8 cavity. The 1:1 Q8•Tyr-Ala-Leu complex was confirmed by ESI-MS (Figure S4). 
Extension of the Tyr-Var Motif.  The contrasting results of Tyr-Leu-Ala and Tyr-Ala-Leu 
described above suggest that the Tyr and Leu residues need to be neighbors in order to bind in a 1:1 
complex with Q8 and with the inclusion of both side chains. It was not clear, however, whether the Tyr-
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Leu binding site needs to be located at the N-terminus. To address this question, the sequence isomer 
Ala-Tyr-Leu was synthesized, purified, and characterized by 1H NMR and ESI-MS (Figures S5 and 
S29). The NMR spectrum of Ala-Tyr-Leu in combination with Q8 (Figure S30) reveals the upfield 
perturbation of chemical shifts for Tyr and Leu side chains and thus their inclusion within the Q8 cavity. 
At substoichiometric ratios of Q8 to Ala-Tyr-Leu, two sets of peptide resonances are observed (free and 
bound), thus revealing a 1:1 complex and slow exchange on the NMR timescale (data not shown). The 
1:1 Ala-Tyr-Leu•Q8 complex was observed by ESI-MS (Figure S6). Therefore, the Tyr-Leu binding site 
does not need to be located at the N-terminus. 
Having established the unique nature of the Tyr-Leu binding site, we then wondered whether this 
motif could extend beyond Var = Leu. In the fluorescence screen described above, Var = Leu was 
chosen for further study because Tyr-Var1-Ala led to an increase in fluorescence, Tyr-Ala-Var2 caused a 
decrease in fluorescence, and the difference between their changes in fluorescence intensity was the 
largest (23%). Among the other peptides for which this pattern was observed, large differences were 
also observed for Var = Phe (21%) and Tyr (18%). Therefore, the peptides Tyr-Phe-Ala, Tyr-Ala-Phe, 
Tyr-Tyr-Ala, and Tyr-Ala-Tyr were individually synthesized, purified, and characterized by 1H NMR 
and ESI-MS (Figures S9, S11, S13, S15, S37, S39, S41, and S43) in order to probe the possible 
extension of this binding motif. The 1H NMR spectra of Tyr-Phe-Ala and Tyr-Tyr-Ala show upfield 
perturbation of both aromatic side chains upon binding to Q8, indicating simultaneous inclusion within 
the host (Figures S38 and 42). In addition, the 2:1 mixtures of peptide:Q8 show a set of bound peptide 
resonances and a set of unbound peptide resonances (data not shown), and thus the kinetics of exchange 
is slow on the NMR timescale, and the complexes had a peptide:Q8 stoichiometry of 1:1. In both cases, 
a 1:1 peptide:Q8 stoichiometry was corroborated by ESI-MS (Figures S10 and S14).  Similar to Tyr-
Ala-Leu, the 1H NMR spectra of Tyr-Ala-Tyr and Tyr-Ala-Phe also show extensive signal broadening 
in the presence of Q8, thus complicating further analysis (Figures S40 and S44). On the basis of these 
data, we conclude that the Tyr-Var motif extends beyond Var = Leu to include Var = Phe and Tyr. 
The Tyr-Var•Q8 complex described here represents a novel binding motif in which the host 
accommodates the inclusion of two neighboring amino acid residues within its cavity and binds in a 1:1 
stoichiometry. Due to the tight fit, the peptide has a very limited range of possible conformations, and 
thus Q8 serves as a template for the induced folding of the peptide. Although the inclusion of two amino 
acid residues within the cavity of a synthetic receptor and the induced folding of a peptide by a synthetic 
receptor are not entirely unique in the literature, they are rare, especially in aqueous media. In particular, 
work by Fujita and coworkers have demonstrated the sequence-specific recognition of multiple amino 
acids and the folding of peptides into alpha helix and beta-turn conformations by self-assembled 
coordination cages, with several complexes of M affinity in aqueous solution.8,30-32 
Thermodynamic Characterization of Peptide Binding.  Thermodynamic constants for binding of 
peptides to Q8 were determined by isothermal titration calorimetry (ITC) (Table 1 and Figures S45-
S50). As expected, all complexes were observed to bind in a 1:1 peptide:Q8 ratio ("n" values were 
within 10% of 1.0). We were surprised to observe that Tyr-Leu-Ala binds Q8 with an equilibrium 
dissociation constant (Kd) value of 7.2 nM.
33 This is, to the best of our knowledge, the strongest 
reported affinity of a synthetic receptor for an unmodified peptide in aqueous solution. This result is 
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further highlighted by the fact that the buffer contains 10 mM sodium, which binds to the host with a Kd 
value of 1 mM10 and thus diminishes the  
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a Mean values measured from at least two ITC experiments at 27 C in 10 mM sodium 
phosphate, pH 7.0. b Gibbs free energy values calculated from Kd values.  Standard deviations for 
G values were calculated as the relative error observed in Kd, due to their relationship by a 
natural logarithm. c Entropic contributions to G calculated from Kd and H values, with error 
propagated from that of Kd and H. 
 
observed binding affinity by 10-fold; therefore, we estimate the Kd of the Tyr-Leu-Ala•Q8 complex to 
be subnanomolar in pure water. The next highest affinity reported in the literature is the binding of Phe-
Gly by Q7 in pure water (Kd = 33 nM), reported by Kim, Inoue, and coworkers.
34 The strong affinity of 
Tyr-Leu-Ala is consistent with the slow exchange kinetics observed in NMR data. The peptide Ala-Tyr-
Leu showed a 430-fold loss in affinity compared to Tyr-Leu-Ala. Therefore, the Tyr-Leu sequence can 
be bound by Q8 at both N-terminal and non-N-terminal positions, but there is substantial specificity for 
N-terminal Tyr-Leu. 
The sequence isomer Tyr-Ala-Leu binds Q8 with a Kd value of 34 M, which is 4700-fold weaker 
than its sequence isomer Tyr-Leu-Ala. This is exceptionally high sequence-specificity for a synthetic 
receptor in aqueous solution, second only to the study reported by Kim, Inoue, and coworkers for the 
binding of Phe-Gly vs. Gly-Phe by Q7 (23,000-fold).34 In their study and others,28,35 specificity for the 
N-terminal Phe is thought derive from the location of the aromatic residue relative to the charged groups 
at each terminus, whereas in the current study, the specificity of Tyr-Leu-Ala vs. Tyr-Ala-Leu is thought 
to derive from inclusion of the second side chain within the Q8 cavity. This hypothesis is supported by 
the enthalpy and entropy data (Table 1). The binding of both Tyr-Leu-Ala and Tyr-Ala-Leu is 
enthalpically driven and entropically unfavorable. The 5.0 kcal/mol difference in the free energy of 
complexation is due mostly to enthalpy (6.0 kcal/mol), whereas the entropic contribution to binding 
energy is similar to within 1 kcal/mol. This observation suggests that, compared to the Tyr-Ala-Leu•Q8 
complex, the Tyr-Leu-Ala•Q8 complex is stabilized by the additional van der Waals interactions of the 
Leu side chain with the Tyr side chain and the walls of the Q8 cavity. Desolvation of the isobutyl group 
may contribute to the entropic stabilization but would be offset by the immobilization of the side chain 
within the tightly packed cavity. The low affinity of the Tyr-Ala-Leu complex was shared by the other 
two Tyr-Ala-Var2 peptides (Tyr-Ala-Tyr and Tyr-Ala-Phe) whose ITC data proved difficult to fit (data 
not shown). 
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The Kd values for Tyr-Phe-Ala and Tyr-Tyr-Ala were 0.29 and 0.70 M, respectively. These 
submicromolar affinities are strong but significantly weaker than that of Tyr-Leu-Ala. Looking back at 
the fluorescence data from the initial library screen, Tyr-Phe-Ala (14%) and Tyr-Tyr-Ala (13%) showed 
a lower extent of fluorescence enhancement than Tyr-Leu-Ala (19%) upon binding to Q8. This 
observation is consistent with a model in which the extent of fluorescence enhancement is proportional 
to the affinity of the peptide and thus the extent of MBBI displacement at a given concentration. Those 
data show Var1 = Lys (i.e., Tyr-Lys-Ala) as the peptide that induces the greatest extent of fluorescence 
enhancement upon binding to Q8 (21%), and so we synthesized, purified, and characterized Tyr-Lys-
Ala by 1H NMR and ESI-MS (Figures S7 and S31). As expected, Tyr-Lys-Ala interacted with Q8 in a 
similar manner the other Tyr-Var peptides by 1H NMR and ESI-MS (Figures S8 and S32-S34). A 
semiempirical model (Figure S37) based on ROESY data (Figure S36) is consistent with the inclusion 
of both side chains, with additional interaction of the side chain ammonium group with the opposite 
carbonyl portal of Q8. Tyr-Lys-Ala binds Q8 with a Kd value of 0.20 M, which is stronger than that of 
Tyr-Tyr-Ala and Tyr-Phe-Ala but weaker than that of Tyr-Leu-Ala. Although we expected Tyr-Lys-Ala 
to bind a little stronger than Tyr-Leu-Ala, based on the fluorescence screen, the observed discrepancy is 
within the error of the fluorescence screen. 
Phenylalanine-Terminated Peptides.  The library screen for phenylalanine-terminated peptides 
(Figure S51) showed that the fluorescence intensity of the Q8•MBBI complex was consistently 
enhanced upon adding peptide.  We thought (vide supra) this result was due to the binding of two 
equivalents of peptide to Q8, because we had observed this result previously for Phe-Gly-Gly.28  In light 
of the results reported here on tyrosine-terminated peptides, however, we revised our thinking on how 
Phe-terminated peptides may displace MBBI.  Given the similarity in structure between Phe and Tyr, 
we predicted that Phe-Leu-Ala, for example, should bind Q8 in a similar fashion as Tyr-Leu-Ala.   
To test this prediction, we synthesized and characterized Phe-Leu-Ala and Phe-Ala-Leu and studied 
their interaction with Q8 by ITC, NMR, and ESI-MS (Figures S54-S68).  Prior work has shown Phe-
terminated peptides to bind with higher affinity than Tyr-terminated peptides to Qn hosts,6 presumably 
due to the greater hydrophobicity of Phe. The semiempirical model of the Q8•Tyr-Leu-Ala complex 
(Figure 5) shows the tyrosine hydroxyl group making no direct contact with peptide or Q8, and thus it 
was reasonable to predict even stronger binding for Phe-Leu-Ala.  The ITC experiments for binding of 
Phe-Leu-Ala to Q8 reveal a 1:1 Q8:peptide stoichiometry and an average Kd value of 0.43 (±0.12) M, 
which is significantly weaker than that of the Tyr analogue.  This is consistent with our prediction that 
Phe-Leu-Ala should bind Q8 in a similar fashion as Tyr-Leu-Ala, but it was surprising that the affinity 
is weaker. The ESI-MS data confirm the presence of 1:1 and 2:1 peptide:Q8 complexes. The NMR data 
confirm the inclusion of Phe and Leu sidechains within the Q8 cavity and thus a similar mode of 
binding as Tyr-Leu-Ala.   
In contrast to the results for Tyr-containing peptides, however, the ITC, NMR, and ESI-MS data for 
the sequence isomer Phe-Ala-Leu reveal a 2:1 peptide:Q8 complex as the dominant species. ITC 
experiments show positive cooperativity, as observed for Phe-Gly-Gly.28 NMR experiments show the 
2:1 Phe-Ala-Leu:Q8 complex, even at substoichiometric ratios (data not shown), and the inclusion of 
only the Phe sidechain within the Q8 cavity, which is also consistent with prior work on Phe-Gly-Gly.  
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These results demonstrate that the increase in fluorescence intensity observed in the library screen can 
be due to 1:1 or 2:1 peptide:Q8 binding, depending on the peptide sequence. 
CONCLUSIONS 
This paper explores the effects of sequence context on the binding of the synthetic receptor 
cucurbit[8]uril (Q8) to peptides containing an N-terminal aromatic residue. Using MBBI as a 
fluorescent indicator, we found that peptides containing an N-terminal Trp bind to Q8 as a second guest, 
causing a decrease in MBBI fluorescence, whereas Phe-terminated peptides displace MBBI from the Q8 
cavity, causing an increase in fluorescence. This novel use of a fluorescent indicator as both turn-off and 
turn-on sensor based on two different binding modes led to the discovery that the mode of binding for 
Tyr-terminated peptides depends on the amino acid sequence. Further study by 1H NMR spectroscopy 
and ESI-MS showed that four peptides of sequence Tyr-Var-Ala (Var = Leu, Lys, Phe, and Tyr), as well 
as Phe-Leu-Ala, displace MBBI and bind to Q8 in a 1:1 stoichiometry with the side chains of both the 
terminal residue and its immediate neighbor bound inside the Q8 cavity. Isothermal titration calorimetry 
experiments corroborated the stoichiometry and gave submicromolar affinity Kd values for these 
peptides. Remarkably, Tyr-Leu-Ala bound to Q8 with a Kd value of 7.2 nM in 10 mM sodium phosphate 
buffer, which is, to the best of our knowledge, the highest reported affinity for a synthetic receptor 
binding to an unmodified peptide in aqueous solution. Moving the Leu residue further away (e.g., Tyr-
Ala-Leu) markedly diminished binding affinity (4300-fold), showing exceptionally high sequence-
specificity.  In the Tyr-Ala-Leu•Q8 complex, only the Tyr residue bound within the Q8 cavity, allowing 
a second equivalent of peptide or MBBI to bind simultaneously. This result is important because it 
brings us significantly closer to the long-standing goal of developing a synthetic receptor that can bind 
peptides in aqueous media with sufficiently high affinity and specificity as to make them, like 
antibodies, practical for applications in biochemistry and biotechnology. Q8 binding to Tyr-Leu-Ala is 
not a general approach to peptide recognition, but Q8 has the advantages of being small, highly stable, 
recyclable,36 and many orders less expensive than a monoclonal antibody. Moreover, this peptide 
sequence is minimal and can be readily engineered into recombinant proteins for use as an affinity tag 
for biological applications.37-39 
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